Daily Ards Research Analysis
A Cochrane network meta-analysis suggests that, as primary non-invasive support for preterm infants, NIPPV and NIHFV may reduce treatment failure or need for intubation versus CPAP/HFNC, though certainty is low and effects on chronic lung disease are minimal. A prospective ARDS study indicates prone positioning improves cerebral oxygenation measured by NIRS. A large retrospective ARDS cohort links elevated direct bilirubin to higher 90-day mortality with a nonlinear risk relationship.
Summary
A Cochrane network meta-analysis suggests that, as primary non-invasive support for preterm infants, NIPPV and NIHFV may reduce treatment failure or need for intubation versus CPAP/HFNC, though certainty is low and effects on chronic lung disease are minimal. A prospective ARDS study indicates prone positioning improves cerebral oxygenation measured by NIRS. A large retrospective ARDS cohort links elevated direct bilirubin to higher 90-day mortality with a nonlinear risk relationship.
Research Themes
- Non-invasive respiratory support strategies in neonatal respiratory distress
- Neuro-monitoring and prone positioning in ARDS
- Hepatopulmonary biomarkers and mortality risk in ARDS
Selected Articles
1. Non-invasive respiratory support in preterm infants as primary mode: a network meta-analysis.
Across 61 trials (7554 neonates), NIPPV and NIHFV may reduce treatment failure and need for intubation compared with CPAP or HFNC, though certainty is low to very low; effects on moderate-severe CLD appear minimal. Evidence is limited for infants <28 weeks’ GA, and many trials did not match mean airway pressures across modes.
Impact: This Cochrane network meta-analysis provides the most comprehensive comparative effectiveness synthesis of primary non-invasive ventilation strategies for preterm infants, informing device selection amid low-certainty evidence.
Clinical Implications: Consider NIPPV or NIHFV as first-line non-invasive support over CPAP/HFNC to reduce early failure/intubation where expertise and equipment are available, while recognizing low-certainty evidence and ensuring equivalent mean airway pressure settings across modes.
Key Findings
- NIPPV reduced treatment failure versus CPAP (network RR 0.63, 95% CrI 0.48–0.82; very low certainty).
- NIHFV reduced treatment failure versus CPAP (network RR 0.41, 95% CrI 0.23–0.69; low certainty).
- Little to no effect on moderate-severe chronic lung disease across modes; evidence generally very uncertain.
- Most studies did not compare modes at equivalent mean airway pressures; infants <28 weeks’ GA were under-represented.
Methodological Strengths
- Cochrane methodology with registered protocol and GRADE assessment tailored for network meta-analysis.
- Comprehensive search across multiple databases and Bayesian mixed treatment comparisons.
Limitations
- Low to very low certainty due to within-study bias, imprecision, and incoherence.
- Non-equivalent mean airway pressures across modes in most trials; paucity of data for GA <28 weeks.
Future Directions: Head-to-head RCTs matching mean airway pressures are needed, especially in infants <28 weeks’ GA, with standardized failure criteria and long-term outcomes.
RATIONALE: Numerous innovations in non-invasive respiratory support have been introduced, resulting in a variety of available modes. Given the many options, understanding the relative effectiveness of these strategies is important. OBJECTIVES: To evaluate the benefits and harms of various non-invasive respiratory support modes when used as primary support in preterm infants. SEARCH METHODS: We searched CENTRAL, MEDLINE, Embase, CINAHL, Web of Science, and trial registries (to 7 January 2024). ELIGIBILITY CRITERIA: Randomised, quasi-randomised, and cluster-randomised controlled trials comparing two or more non-invasive respiratory support modes used as primary support for preterm infants within the first 24 hours. OUTCOMES: Critical outcomes included treatment failure, endotracheal ventilation, and moderate-severe chronic lung disease (CLD).
2. Prone Positioning to Improve Cerebral Oxygenation in Patients With Acute Respiratory Distress Syndrome.
In 10 ARDS patients, prone positioning increased rSO2 and the rSO2/FiO2 ratio from hours 3–12, with rSO2 correlating strongly with oxygen delivery (ρ=0.811) and moderately with cardiac index (ρ=0.463). Findings suggest prone positioning may enhance cerebral oxygenation, though two patients discontinued early due to instability.
Impact: This study connects a cornerstone ARDS therapy (proning) to cerebral oxygenation, addressing the neurocritical dimension of ARDS management.
Clinical Implications: Consider NIRS-based cerebral oxygenation monitoring during prolonged proning to individualize supportive care and mitigate acute brain injury risk.
Key Findings
- Prone positioning increased the rSO2/FiO2 ratio significantly at hours 3, 8, and 12.
- Regional cerebral oxygen saturation (rSO2) correlated with oxygen delivery (ρ=0.811, P<.001) and cardiac index (ρ=0.463, P<.001).
- Two of ten patients discontinued proning early due to hemodynamic instability.
Methodological Strengths
- Prospective design with within-patient pre-post comparisons.
- Continuous NIRS-based monitoring during a standardized 18-hour prone session.
Limitations
- Small single-center sample (n=10) without control group.
- Early discontinuation in two patients and limited generalizability.
Future Directions: Larger multicenter studies should validate NIRS-guided strategies during proning and assess neurological outcomes.
BACKGROUND: Acute respiratory distress syndrome (ARDS), a common condition among intensive care patients, is characterized by severe hypoxemia that may lead to acute brain injury. Although prone positioning has emerged as a lifesaving strategy in the management of ARDS, its effects on cerebral oxygenation remain insufficiently explored. OBJECTIVE: To evaluate the evolution of cerebral oxygenation during prone positioning in patients with ARDS. METHODS: This prospective, single-center study was done in the intensive care unit of a community hospital. Consecutive patients with moderate or severe ARDS were prospectively enrolled during a 12-month period. Cerebral oxygenation was assessed by near-infrared spectroscopy before and during an 18-hour period of prone positioning.
3. Association between serum direct bilirubin and 90-day mortality in patients with ARDS: A retrospective analysis.
Among 714 ARDS patients, DBIL >1.05 mg/dL was associated with lower survival (52.2% vs 73.7%) and independently predicted 90-day mortality (HR 1.76, 95% CI 1.33–2.33) and in-hospital mortality (HR 1.99, 95% CI 1.59–2.50). Indirect bilirubin was not predictive; the DBIL–mortality relationship was nonlinear.
Impact: This study highlights hepatopulmonary crosstalk in ARDS by identifying direct bilirubin as an independent, nonlinear predictor of mortality using a large ICU database.
Clinical Implications: Monitor and trend DBIL in ARDS as part of risk stratification; elevated DBIL may prompt closer monitoring, evaluation for hepatic dysfunction, and consideration of organ support strategies.
Key Findings
- DBIL >1.05 mg/dL was associated with markedly lower 90-day survival (52.2% vs 73.7%; P<.001).
- Elevated DBIL independently predicted 90-day mortality (HR 1.76, 95% CI 1.33–2.33) and in-hospital mortality (HR 1.99, 95% CI 1.59–2.50).
- Indirect bilirubin was not associated with 90-day mortality; DBIL–mortality association was nonlinear (P for nonlinearity = .002).
Methodological Strengths
- Large ICU cohort (n=714) identified by Berlin ARDS criteria with multivariable Cox modeling.
- Use of restricted cubic splines to characterize nonlinear risk relationships.
Limitations
- Retrospective single-database design with potential residual confounding.
- DBIL thresholds and timing relative to ARDS onset may vary; causality cannot be inferred.
Future Directions: Prospective validation of DBIL-based risk stratification, dynamic trajectory analyses, and mechanistic studies of hepatopulmonary interactions in ARDS.
The liver plays a key role in the pathogenesis and resolution of acute respiratory distress syndrome (ARDS). Clinically, elevated serum bilirubin - especially direct bilirubin (DBIL) - is frequently observed in ARDS. This study aimed to evaluate the association between DBIL levels and 90-day mortality in ARDS patients. This retrospective cohort study used data from the MIMIC-IV database. ARDS patients were identified based on the Berlin definition. The primary outcome was 90-day all-cause mortality; in-hospital mortality was secondary. Cox proportional hazards models assessed the association between DBIL levels and mortality. Restricted cubic spline regression examined nonlinear relationships.